Reducing DNA repair protein levels to target root cause of Huntington’s disease
Researchers from the Huntington’s Disease Center, UCL Queen Square Institute of Neurology, and UK DRI at UCL have taken major steps forward in advancing MSH3-targeting therapies for Huntington’s disease (HD). Their study is published in Science Translational Medicine.
